PPARA and breast cancer: To examine the effects of SRC-1 null mutation on mammary tumorigenesis in vivo, we created SRC1-/-;neu and SRC1+/+;neu mice and characterized mammary tumors arising in these animals following administration of PPAR or RXR ligands.